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Voacanga foetida (Bl.) K.Schum leaves are known to have cytotoxic activity against blood
cancer cells. This study was aimed to determine the potential of an isolated butanol fraction
of Voacanga foetida (Bl.) K.Schum leaves (Tb3 compound) in inhibiting the proliferation of
several cancer cells, including leukemia (K562), lung cancer (A549), and cervical cancer (HeLa) using the dye exclusion method. We found that the percentage of anti-proliferation of the
Tb3 compound was increased in a dose-dependent manner, where it showed 83% (K562), 72.3%
(He-La), and 70.7% (A549) inhibition at higher concentration. These values were relatively
higher compared to doxorubicin as a positive control, 77.1%, 63.8%, and 62.7%, respectively.
Moreover, the IC50 values of the Tb3 compound were still in the range of active cytotoxic
compounds based on NCI classification, which is less than 4 µg/mL; 0.5 μg/mL, 2.4 μg/mL,
and 3.6 μg/mL for K562, A549, and He-La, respectively. Therefore, this study indicated the
potential anticancer effect of an isolated butanol fraction of the Tb3 compound to inhibit cancer
cell proliferation, which provides an alternative for cancer therapy.
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INTRODUCTION
In 2018 alone, GLOBOCAN has estimated 18.1
million new cancer cases and 9.6 million cancer deaths
worldwide, which lung cancer was the most commonly
diagnosed (13%) and shared the highest percentage of
death (23.5%) (Siegel et al., 2019). The rate of new cases
is then closely followed by leukemia (3.5%) and cervical
cancer (0.8%), whereas the mortality cases were 0.7%
and 3.8%, respectively (Siegel et al., 2019). Similar to
this, the percentage of mortality in Indonesia is also
higher for lung cancer, leukemia, and cervical cancer
than the new cases rate, which amounted to 12.6%,
8.8%, and 5.5%, respectively. This trend is likely due
to the poorer prognosis and limited access to timely
diagnosis and treatment (IARC, 2018). However, this
cancer prevalence can be reduced significantly through
preventive measurement, early detection, and effective
treatments (Riskesdas, 2013).
One breakthrough in cancer drug development is the use
of natural compounds. Many natural compounds have

been well investigated and effective as an anticancer
treatment (Cui et al., 2018). Ideally, the anticancer drug
should immediately kill cancer cells without endangering
neighboring healthy cells. However, the standard cancer
therapies, such as chemotherapy, radiotherapy, and
surgery, can attack normal surrounding cells/tissues and
induce several intolerable side effects. For instance, hair
loss, nausea, vomiting, diarrhea, susceptibility to getting
an infection, thrombocytopenia, neuropathy, and myalgia
might lead to ineffective treatment for some cancer
patients (Nurgali et al., 2018). Moreover, even cancer
surgery could not remove the malignant cells entirely
(Dipiro et al., 2011). Therefore, anticancer drugs derived
from natural compounds, known as chemoprevention,
could be used as an alternative treatment.
Voacanga foetida (Bl) K. Schum (Apocynaceae),
locally called ‘Tampa badak,’ is a plant species mainly
distributed in Sumatra, Indonesia. The aqueous extract
of V. foetida leaves or bark is commonly used to treat
a wide range of skin conditions such as wounds,
itches, swellings, and antimicrobial (Hadi et al., 2019).
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Another study revealed that V. foetida leaves also have
anti-inflammatory, antipyretic, and analgesic activity
(Susanty et al., 2014). A recent study found that V. foetida
leaves are also potential as anticancer (Susanty et al.,
2018) because the rich in alkaloids, such as voacangine,
coronadine, voacristine, lombine (Hadi, 2019), and
vobtusine (Arbain, 2012), which these substances have
a potent effect of cytotoxic activity. Therefore, we aimed
to evaluate the cytotoxic effect of V. foetida leaves
on several cancer cell types, including lung cancer,
leukemia, and cervical cancer.
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whereas the stained TLC plate was seen under a UV
lamp. The combination of eluents was monitored and
resulting in three different fractions. The purification was
then performed in this fraction, and recrystallization was
carried out to remove impurities. After recrystallization,
the Tb3 compound was obtained as much as 301 mg
(Figure 1).

MATERIALS AND METHODS
Materials
V. foetida leaves were collected from the Lembah Anai
forest in Sumatera Barat. The Tb3 compound has resulted
from an isolated butanol fraction of V. foetida leaves.
K562, A549, and He-La cell line were obtained from
the American Type Culture Collection (Rockville, MD)
and were cultured in DMEM (GIBCO, Invitrogen Corp.,
New Zealand) with 10% (v/v) FBS (Bio-west, Japan)
100 mg/L of streptomycin, and 100.000 U/L of penicillin
at 37°C (Wako, Japan) and 5% CO2.
Methods
Isolation and extraction of Tb3 compound
The extraction process was carried out by maceration
using ethanol 96% solvent with three times replication
for approximately five days through occasional stirring,
and then filtered with cotton and transferred to the filtrate
into a closed vessel. We used a rotary evaporator to
obtain a thick ethanol extract of V. foetida leaves for a
total weight of 65 g. The thick ethanol extract for about
15 g was taken for further fractionation process, using
a separating funnel with n-butanol as the solvent. The
rotary evaporator was used again to get a concentrate.
From this process, about 10 g of butanol fraction was
obtained.
Thin-layer chromatography (TLC) analysis
The butanol fraction was poured into the TLC plate and
put into a chamber containing a different gradient of
hexane:ethyl as eluent. The SGP (Step Gradient Polarity)
was used for the eluent gradients (Table 1). The column
was then stored in vials and allowed to evaporate,

Figure 1. Tb3 Compound, shaped yellow-white
needle-shaped crystal, weighing 301 mg.
Identification of chemical functional group
The characterization of the Tb3 compound was assessed
using UV and IR spectrophotometry. This compound
was also analyzed for the melting point using a Fisher
John. The various eluent gradients on the TLC plate was
tested for steroids by given a Lieberman Burchad color
reagent, which the positive result was indicated with a
blue color.
Cell proliferation assay
This assay was aseptically carried out in the laminar airflow cabinet (LAF-cabinet). Cancer cells (K562, A549,
and He-La) containing 2x105 cells /mL in DMEM medium
placed in 24 well plates. The isolated Tb3 compound in
the DMSO solvent at six different concentrations (0 µg/
mL (negative control, only DMSO 10 µL); 0.5; 1; 2; 4;
8 µg/mL) were exposed to the cancer cells. The cells
were then incubated for 72 hours at 37°C and 5% CO2.
We did triplicate for each condition, and the assay was
carried out three times. After the incubation, the medium
was removed from the well, and 40 µL trypsin-EDTA
0.2% was added (approximately 8 minutes incubation)
to detach the remaining cells at the bottom of the well.

Table 1. TLC test results for Tb3 compound with different eluents gradients

E-ISSN 2477-0612

No

Eluent

Eluent gradients

Rf Values

1
2
3
4

n-hexane:ethyl acetate (A)
n-hexane:ethyl acetate (B)
n-hexane:ethyl acetate (C)
ethyl acetate (D)

7:3
6:4
5:5
100 %

0.25
0.50
0.62
0.67
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Subsequently, 960 µL of fresh medium was added to the
well, and the cell suspension was gently mixed with a
micropipette until homogeneous. A total of 90 µL of this
cell suspension was moved to 96 wells plate, and 10 µL
of 1% trypan blue was added to the well. The plate was
shaken until homogeneous, then 10 µL of the mixture
was dripped into an Improved Neubauer hemocytometer
chamber gap to count the number of living cells in 25
boxes in the center of the counting chamber. Living cells
were seen as transparent spheres with the cell nucleus
in the middle of the areas, while dead cells were in
irregularly formed blue patches. Cells were counted
three times in five medium fields located in the middle of
the massive plane. The five planes consist of four planes
on edge, and one plane in the center (marked R), which
the overall area is 80x1/400 mm2=0.2 mm2. The counting
was started in a clockwise way. All cells in the upper
and left boundary lines were considered for counting,
whereas cells in the right and bottom boundaries were
not included. The number of living cells per mL,
percent proliferation, and percent anti-proliferation were
calculated by the modified formula (Doyle & Griffith,
2000):
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Figure 2. Thin Layer Chromatography (TLC) of Tb3
Compound (A, B, C, and D). (A) TLC with hexane
eluent:ethyl acetate ratio of 7: 3 with an Rf value of
0.25. (B) TLC with hexane eluent:ethyl acetate ratio
of 6: 4 with an Rf value of 0.5. (C) TLC with hexane
eluent:ethyl acetate ratio of 5: 5 with an Rf value of
0.62. and (D) TLC with 100% Ethyl acetate eluent
with an Rf value of 0.67.

Number of cells in the counting cells

∑Cells

=

% proliferation

= Mean of living cells in negative control media (DMSO)

The volume of the hemocytometer chamber (mL)
Mean of living cells in treatment media

x 100%

% Anti-proliferation = 100% - % Proliferation
The cancer cell inhibition was expressed by the IC50
value in which the concentration of isolated compounds
in µg/mL medium can inhibit 50% of cell proliferation in
the incubation period of 72 hours. The IC50 value of the
test solution was determined based on the equation of the
relationship curve of the test solution concentration with
the percentage of cancer cell death.
Data analysis
The percentage of anti-proliferation was plotted to
the probit table to obtain the probit value. A curve was
made between log concentration (x) and probit (y) to get
a linear regression equation y=a+bx, by entering an of
y=5 in probit scale (probit of 50%) and a value of x (log
concentration). The IC50 was determined by converting
the concentration log value to the form of an antilog.
RESULTS AND DISCUSSION
The ethanol extract of V. foetida leaves (10 g) or called
Tb3 compound was obtained from an isolated butanol

fraction because this fraction is known to have rich
alkaloids and steroids when check it using Thin-Layer
Chromatography (TLC) analysis (Figure 2). The
purification of this fraction was performed to remove
the impurities, and the characterization was carried out
using UV and Infrared spectrophotometry. Through
the TCL analysis, we found that the gradient of hexane
eluent:ethyl acetate ratio of 7:3 gives a better result
of Tb3 compound’s purity, which is characterized by
the melting point of 128°-130°C when identified by
Fisher John. The result of UV spectrophotometry of
Tb3 compounds in methanol solvents showed three
consecutive wavelengths of 271.40 nm (0.491), 281.80
nm (0.522), and 293.40 nm (0.316), in which 281.80 nm
was suggested as λmax due to the n-electron * electron
transition by a carbonyl chromophore (C=O) (Table 2,
Figure 3). Moreover, we identified several functional
groups through IR spectrum, including -OH (3419.79
cm-1), =CH aliphatic alkene group (3024.38 cm-1), CH
aliphatic group (2868.15 cm-1), =CH aromatic alkene
group (1375.25 cm-1), C-O (1058.92 cm-1), and C=O
E-ISSN 2477-0612
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Table 2. The wavelength and absorbance of Tb3
compound at hexane eluent:ethyl acetate ratio of 7: 3
Wavelength (nm)

Absorbance

271.40
281.80
293.40

0.491
0.522
0.316

Table 3. Absorptions of functional groups of Tb3
compound using Infrared spectrum at hexane
eluent:ethyl acetate ratio of 7: 3

Figure 3. UV spectrophotometer of Tb3 compound at
hexane eluent:ethyl acetate ratio of 7: 3
(1600.92 cm-1) (Table 3, Figure 4). Most of the steroids
have the property of containing oxygen functional
groups as C=O. Therefore, to test if the Tb3 compound
belongs to the steroids class, we performed qualitative
testing by Lieberman Burchad color reagent on TLC
plates, and the result gave a blue color, which indicated
a positive result.
To further test the cytotoxic effect of the Tb3 compound
in cancer, we used three types of cancer cells, such as
blood cancer cells (K562), lung cancer cells (A549),
and cervical cancer cells (He-La). We determined the
percentage of anti-proliferation and the IC50, where we
used doxorubicin as a positive control. The percentage
of anti-proliferation was presented in Table 4. We found
that the percentage of anti-proliferation of the Tb3
compound was increased in a dose-dependent manner,
where it showed 83% (K562), 72.3% (He-La), and
70.7% (A549) inhibition at higher concentration (Figure
5). Meanwhile, the percentage of anti-proliferation of
doxorubicin in K562, A549, and He-La are 77.1%,
63.8%, and 62.7%, respectively (Figure 6). These values
were relatively lower than the Tb3 compound, suggesting

Wavenumber
(cm-1)
3419.79 cm-1
3024.38 cm-1
2868.15 cm-1
1600.92 cm-1
1375.25 cm-1
1058.92 cm-1

Description
OH stretch
= CH (aliphatic alkene group).
CH aliphatic strain group
stretch group C = O
= CH (aromatic alkene group)
C-O stretch

that the Tb3 compound has a similar effect in inhibiting
cancer cell growth as strong as doxorubicin (Table 4).
However, the IC50 of the Tb3 compound was relatively
higher compared to doxorubicin, 0.5 μg/mL, 2.4 μg/mL,
and 3.6 μg/mL for K562, A549, and He-La, respectively.
Whereas, the IC50 of doxorubicin in three consecutive
cells are 0.14 μg/mL, 0.15 μg/mL, and 0.18 μg/mL. We
used the IC50 value to determine the concentration that
can kill 50% of cancer cells or induce cytotoxic activity.
It is notably known that doxorubicin is an anthracycline
class of chemotherapy agents with a broad spectrum of
anticancer activity and has been widely used in various
cancer types. Besides being sensitive to lung cancer
cells, doxorubicin is also responsive and potential to
other diseases such as cervical cancer. This compound
is specific to the S phase in the cell cycle by inducing
template disturbances through the intercalation of DNA

Table 4. The percentage of the anti-proliferation effect of Tb3 compound and doxorubicin in K562, A549 and
He-La cell lines
Anti-proliferation (%)
Tb3 Compound
K562
A549
He-La

0.5 µg/mL
52.1
20.7
3.4

1 µg/mL
54.3
34.5
17.0

2 µg/mL
68.1
50.0
34.0

4 µg/mL
77.7
60.4
52.5

8 µg/mL
83.0
70.7
72.9

IC50
(µg/mL)
0.5
2.4
3.6

Doxorubicin
K562
A549
He-La

0.04 µg/mL
18.9
34.5
35.6

0.08 µg/mL
34.4
44.5
39.0

0.16 µg/mL
59.8
51.7
49.2

0.32 µg/mL
67.2
56.9
57.6

0.64 µg/mL
77.1
63.8
62.7

0. 1
0. 2
0. 2
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Figure 4. Infrared spectrophotometer of Tb3 compound at 7: 3 ratio of n-hexane and ethyl acetate

Figure 5. The percentage of the Tb3 anti-proliferation
effect in a dose-dependent manner. Values represent
the mean of triplicate. Data represented as Mean
±SEM.

Figure 6. The percentage of doxorubicin antiproliferation effect in a dose-dependent manner
as a positive control. Values represent the mean of
triplicate. Data represented as Mean±SEM.

base pairs, which leads to DNA strands breakage and
impede DNA and RNA synthesis (Denard, Lee & Ye,
2012) Another possible mechanism is by involving the
binding of cell membrane lipids that will change various
cellular functions and interact with DNA topoisomerase
II to form DNA cutting complexes (Taymaz-Nikerel et
al., 2018). Although the IC50 values of Tb3 compound
in different cell types were higher than doxorubicin,
the Tb3 compound is still adequate to induce cytotoxic
activity because the values are still in the range of
active cytotoxic compounds based on NCI classification
because it is less than 4 µg/mL (Nurestri et al., 2009).
Nevertheless, the plausible mechanism on how the
Tb3 compound inhibit cancer cells needs to be fully
elucidated.

than the butanol fraction of Tb3 compound, which was
rich in steroids. Therefore, this study showed that the
butanol fraction of Tb3 compound has more cytotoxic
activity than voacangine.

According to Macabeo et al., 2009, the alkaloid
compound of vocangine isolated from V.foetida has
known to have potential anticancer activity. A recent
study has reported that the IC50 of voacangine on HEPG2, A375, MDA-MB-231, SH-SY5Y, and CT26 cancer
cells, were 10, 14, 8, 7.6, and 11 µg / mL, respectively
(Chen et al., 2016). These values were somewhat higher

Besides, previously showed that voacangine could
mediate cell apoptosis in THP-1 and HUVEC cells
up to 80% when treated at a concentration with high
concentration (Fiqueirado et al., 2010). Therefore, it
suggested that the cytotoxic activity of the Tb3 compound
probably could also mediate apoptosis. However, we
do not include an apoptotic induction test due to the
limitations of the Tb3 compound and the materials. The
cytotoxic test is performed to confirm whether the Tb3
compound can be toxic or inhibit cancer cells growth.
Apoptosis is a natural process of active cell death, in
which cancer cells are brilliant in avoiding this process
(Wong, 2011). Thus, this assay should be performed
to determine how the mechanism of action of the Tb3
compound inhibits cancer cell growth.
The cancer treatment strategy is to return the apoptotic
signaling pathway to its normal state so that it has the
E-ISSN 2477-0612
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potential to reduce and eliminate cancer cells (Elmore,
2007). In contrast, necrosis is described as a passive cell
death due to environmental disorders by releasing cellular
contents, which causes uncontrolled inflammation (Fink
& Cookson, 2005). Therefore, further studies need to
be taken by adding an apoptotic activity assay using the
flow cytometry with Annexin V-PI method to explain
the cytotoxic activity of the Tb3 compound, more
specifically whether by inducing apoptosis or necrosis.
Annexin V is a recombinant phosphatidylserine-binding
protein that interacts strongly and specifically with
phosphatidylserine residues and can be used to detect
apoptosis (Niu & Chen, 2010).
CONCLUSION
The butanol fraction of the Tb3 compound has potential
anticancer effect in several types of cancers, including
leukemia, lung cancer, and cervical cancer.
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